Evidence map›Paper›PMID 42002722›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia.

Malgorzata Gorniak-Walas, Narasimha S Telugu, Ina-Maria Rudolph, Sebastian Diecke, Thomas E Willnow

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Malgorzata Gorniak-WalasDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Narasimha S TeluguTechnology Platform for Pluripotent Stem Cells, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Ina-Maria RudolphMolecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Sebastian DieckeTechnology Platform for Pluripotent Stem Cells, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Thomas E WillnowDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.

Funding

Novo Nordisk Foundation NNF18OC0033928
6 · The paper itself

Abstract

introductionThe rs11218343 is a non-coding variant of genome-wide significance for sporadic Alzheimer's disease (AD) with one of the most protective effects known to date. It localizes to SORL1, encoding the AD risk factor Sortilin-related receptor with A type repeats (SORLA). Still, the functional significance of rs11218343 for AD-related processes remains unclear.

methodsWe used induced pluripotent stem cell (iPSC) lines from donors, or genome-engineered to carry major and minor rs11218343 alleles, to study the impact of rs11218343 on cellular activities.

resultsWe show that rs11218343 is uniquely linked to functional expression of SORLA in microglia, with increased expression in the protective allele correlating with reduced pro-inflammatory responses. These anti-inflammatory effects are seen in donor lines but not in single nucleotide polymorphism (SNP) -engineered isogenic lines, arguing that this polymorphism alone is insufficient but acting context-dependent. DISCUSSION: Our data infer genetically defined expression of SORL1 in microglia as a determinant of protection from pro-inflammatory stimulation, a function likely encoded by a haplotype linked to rs11218343.

Indexed as

Alzheimer DiseaseLDL-Receptor Related ProteinsMembrane Transport ProteinsMicrogliaPolymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansInduced Pluripotent Stem CellsLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanfunctional validation of risk genotypegenome‐wide associationhuman induced pluripotent stem cellsmicrogliapro‐inflammatory responseSORLAsporadic Alzheimer disease

Identifiers

PMID42002722
PMCPMC13092420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.